Katherine Fiala, MD
MOHS-Micrographic Surgery · Temple, TXNPI 1538372461
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $261 of the $360 with a category attached, or 72.5%. 6 manufacturers reported payments, led by Pfizer at 45.7% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in TX, where the typical reported total is $1,382.
Across 10 payments — averaging $36.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$165
- AstraZeneca$120
- AbbVie$20
- Novartis$19
- Sanofi$18
- Genentech USA, Inc.$18
Across 4 payments — averaging $8399.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$34K
What the payments were for
- Food & beverage$26173%
- Education$9927%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 5 | $165 |
| AstraZeneca | 1 | $120 |
| AbbVie | 1 | $20 |
| Novartis | 1 | $19 |
| Sanofi | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAGRISSO$120
How this compares
$360 in reported general payments places this provider in the 15th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 50 | $419,886 |
| Skyrizi PenRisankizumab-Rzaa | 20 | $403,272 |
| Dupixent PenDupilumab | 13 | $49,699 |
| Clobetasol Propionate | 103 | $2,520 |
| Ketoconazole | 127 | $1,754 |
| Tacrolimus | 18 | $1,662 |
| Pentoxifylline | 14 | $1,310 |
| Triamcinolone Acetonide | 90 | $1,300 |
| Fluorouracil | 28 | $1,127 |
| Fluocinonide | 33 | $1,097 |
| Minoxidil | 62 | $1,017 |
| Metronidazole | 25 | $779 |
| Clindamycin Phosphate | 32 | $757 |
| ValacyclovirValacyclovir Hcl | 21 | $549 |
| Hydrocortisone | 33 | $420 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Temple
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
- Saira MominGrapevine$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.